SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc.
NNVC 1.120-7.4%Jan 9 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: drkaz who wrote (10202)5/8/2018 3:03:34 PM
From: BoredMember  Read Replies (1) of 12873
 
I didn't ask if you regard Nanoviricides as successful. The question was "Do you believe Dr. Anil Diwan considers Nanoviricides "successful"?

You answered:

As Dr. Diwan definitely owns a piece of TheraCour, he should definitely view NNVC as a success for him personally to this point. It has provided him a steady and reliable income to do the R&D that he currently is profiting from....
(emphasis mine)

There's your answer. Nanoviricides has been extremely successful. What matters is how one defines success. If you're a shareholder then likely this has been very unsuccessful. If you are Dr. Anil Diwan, then likely this has been very successful. And will continue to be for the near term.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News